The settlement also includes APP's agreement to dismiss its appeal of the August 2010 federal district court decision holding that MDCO's application for Hatch Waxman patent term extension of the Angiomax composition of...
The Medicines Company (MDCO) has settled the lawsuits filed in the US district court for the district of Delaware relating to the Abbreviated New Drug Application (ANDA) filed by APP Pharmaceuticals, LLC (APP)...
HALLE, Germany -- Scil Proteins, a private biotech company specialized in the research, development and production of recombinant proteins, announced today that it has signed a supply agreement with Actavis, one of the...
DUBLIN -- Research and Markets (http://www.researchandmarkets.com/research/2458e4/myocardial_infarct) has announced the addition of GlobalData 's new report "Myocardial Infarction (MI) Therapeutics - Pipeline Assessment and Market Forecasts to 2018" to their offering. GlobalData, the industry...
DUBLIN -- Research and Markets (http://www.researchandmarkets.com/research/318c2f/france_pharmaceuti) has announced the addition of the "France Pharmaceuticals and Healthcare Report Q1 2012" report to their offering. Despite the government's focus on fiscal consolidation - which includes...
MIAMI BEACH, Fla. -- Nonstop nosebleeds can be serious and frightening, often sending people to the emergency room where their noses are packed with gauze. When that doesn't work, nosebleeds can be halted...
DUBLIN -- Research and Markets(http://www.researchandmarkets.com/research/db02ae/venous_thromboembo) has announced the addition of GlobalData 's new report "Venous Thromboembolism (VTE) Therapeutics - Pipeline Assessment and Market Forecasts to 2018" to their offering. GlobalData, the industry analysis...
Patient/Caregiver, Clinician and Health System Interventions Aim to Increase Quality of Care and Reduce Risk of Stroke through Improved Information and Communication WASHINGTON -- Four interventions to enhance the care and treatment of...
LOS ANGELES -- California-based NantWorks, LLC, announced plans today to locate a new pharmaceutical manufacturing plant in Terre Haute, Indiana, creating up to 234 new jobs by 2016. The pharmaceutical company plans to...
DUBLIN -- Research and Markets(http://www.researchandmarkets.com/research/a6ea07/new_zealand_pharma) has announced the addition of the "New Zealand Pharmaceuticals and Healthcare Report Q1 2012" report to their offering. While New Zealand has a highly developed healthcare services system,...
DUBLIN -- Research and Markets (http://www.researchandmarkets.com/research/2bd809/genentech_inc_c) has announced the addition of iCD Research's new company profile "Genentech, Inc.: Company Profile and SWOT Analysis" to their offering. Key Highlights Genentech, Inc. (Genentech) is among...
HEADNOTE PHYSICIANS AT LUCILE PACKARD CHILDREN'S HOSPITAL LEVERAGE DATA FROM THEIR EHR FOR PEDIATRIC CARE RY MARK HAGLAND For the first time, aggregate patient data from an electronic health record (EHR) has been...
The mapping of the human genome is helping to usher in a more personalized approach to medical intervention. Knowledge of an individual's genomic makeup can help predict if that person might be predisposed...
Out of 240 branded pharma websites, only about a fifth have any African American imagery on their pages, and bilingual sections of pharma sites are often missing important elements like the "Questions to...
Strengths One of the largest pharmaceutical companies in Israel. Strong position of generic drugs on the local market. Diverse product portfolio. Presence in the US through an affiliate company. Weaknesses Unattractive domestic market....
Strengths One of the leading foreign pharmaceutical companies in Serbia. Extensive range of prescription medicines, as well as OTCs and animal health products. Long history of involvement in the Serbian market. Weaknesses Strong...
Strengths One of market leaders in Serbia, with a large and diversified product portfolio. Long-established relationships with state authorities. Extensive network of offices in the country. The only producer of APIs in Serbia....
Strengths Third largest domestic manufacturer, after Takeda and Astellas. Healthy financial position amid stagnating local market. Strong overseas presence in developed markets. Also has a strong presence in India through its stake in...
SWOT Analysis Strengths Aventis and Sanofi-Synthelabo had an established presence in Argentina prior to their merger, with the combined operations providing greater scale and synergies.It is present in the key animal health segment...